Pakistanis angry over detentions in Times Sq. case Monday, May 24, 2010
ISLAMABAD – Relatives of three men detained by Pakistan for alleged links to the suspect in the attempted Times Square bombing say the men are innocent.
They
AFP - Thursday, August 6TAIPEI (AFP) - - Taiwan's Beijing-friendly government on Wednesday denied boycotting an Australian film festival amid a row over the e
BERLIN (Reuters) - Chancellor Angela Merkel suffered a double blow on Thursday as a senior party ally in east German
Minister seeks closure of anti-Berlusconi websites Wednesday, December 16, 2009
ROME (AFP) - – The Italian government moved Tuesday to close down Internet sites encouraging further violence against Prime Minister Silvio Berlusconi, who
By ELAINE KURTENBACH,AP Business Writer AP - Wednesday, March 18SHANGHAI - Asia's stock market rally seemed to be running out of steam Wednesday, despite an
Edition:
U.S.
Africa
Arabic
Argentina
Brazil
Canada
China
France
Germany
India
Italy
Japan
Latin America
Mexico
Russia
Spain
United Kingdom
Home
Business
Business Home
Economy
Technology
Media
Small Business
Legal
Deals
Earnings
Social Pulse
Business Video
The Freeland File
Markets
Markets Home
U.S. Markets
European Markets
Asian Markets
Global Market Data
Indices
M&A
Stocks
Bonds
Currencies
Commodities
Futures
Funds
peHUB
World
World Home
U.S.
Brazil
China
Euro Zone
Japan
Mexico
Russia
India Insight
World Video
Reuters Investigates
Decoder
Politics
Politics Home
Election 2012
Issues 2012
Candidates 2012
Tales from the Trail
Political Punchlines
Supreme Court
Politics Video
Tech
Technology Home
MediaFile
Science
Tech Video
Tech Tonic
Social Pulse
Opinion
Opinion Home
Chrystia Freeland
John Lloyd
Felix Salmon
Jack Shafer
David Rohde
Bernd Debusmann
Nader Mousavizadeh
Lucy P. Marcus
David Cay Johnston
Bethany McLean
Edward Hadas
Hugo Dixon
Ian Bremmer
Mohamed El-Erian
Lawrence Summers
Susan Glasser
The Great Debate
Steven Brill
Jack & Suzy Welch
Breakingviews
Equities
Credit
Private Equity
M&A
Macro & Markets
Politics
Breakingviews Video
Money
Money Home
Tax Break
Lipper Awards 2012
Global Investing
MuniLand
Unstructured Finance
Linda Stern
Mark Miller
John Wasik
James Saft
Analyst Research
Alerts
Watchlist
Portfolio
Stock Screener
Fund Screener
Personal Finance Video
Money Clip
Investing 201
Life
Health
Sports
Arts
Faithworld
Business Traveler
Entertainment
Oddly Enough
Lifestyle Video
Pictures
Pictures Home
Reuters Photographers
Full Focus
Video
Reuters TV
Reuters News
Article
Comments (0)
Counterparties: Today's Best Links
Johnson: JOBS Act a "collosal mistake of historic proportions"
A bill intended to help startups could turn back decades of regulation and amounts to a "bipartisan route to disaster," former IMF chief economist Simon Johnson writes. Read more at Counterparties
Why America is about to fall off a "fiscal cliff"
Obama vs. Romney: Where it stands today
Follow Reuters
Facebook
Twitter
RSS
YouTube
Read
Republican budget draws election contrast with Obama
12:12pm EDT
Starbucks goes beyond coffee with first juice bar
19 Mar 2012
Chavez sees plot to kill Venezuela opposition rival
19 Mar 2012
Asma al-Assad: a "desert rose" crushed by Syria's strife
19 Mar 2012
France fears Jewish school gunman could strike again
|
11:46am EDT
Discussed
187
Dozens arrested at Occupy’s 6-month anniversary rally
154
Exclusive: U.S., Britain to agree emergency oil stocks release
119
Santorum to Puerto Rico: Speak English if you want statehood
Watched
Benghazi marks first anniversary of victory over Gaddafi forces
Mon, Mar 19 2012
Storm leaves devastation in Australia
Mon, Mar 19 2012
Romney calls Santorum an 'economic lightweight'
Mon, Mar 19 2012
Japan's scandal-hit Olympus to launch new medical devices
Tweet
Share this
Email
Print
Related News
Japan prosecutors charge key figures in Olympus scandal
Wed, Mar 7 2012
Japan watchdog files criminal complaint against Olympus
Tue, Mar 6 2012
Olympus risks foreign backlash with new board line-up
Mon, Feb 27 2012
UPDATE 5-Olympus risks foreign backlash with new board line-up
Mon, Feb 27 2012
Foreign investors fear Japan banks may hijack Olympus board
Tue, Feb 21 2012
Analysis & Opinion
Corporate governance: boardrooms fret over corporate espionage and federal guidance regimes
Japan quake anniversary shows lessons unlearned
Related Topics
Health »
Tech »
Japan »
Olympus Corp's Executive Officer Hiroyuki Sasa (L), President Shuichi Takayama (2nd L), Independent Directors Hiroshi Kuruma (2nd R) and Yasuo Hayashida bow during a news conference in Tokyo February 27, 2012.
Credit: Reuters/Toru Hanai
TOKYO |
Tue Mar 20, 2012 7:21am EDT
TOKYO (Reuters) - Japan's Olympus Corp will unveil new endoscopes on Wednesday, its first major product launch since an accounting fraud erupted last year and threatened the 92-year-old firm's survival.
The medical equipment maker has withstood one of Japan's worst corporate scandals partly because of its profitable endoscope business, which accounts for the bulk of its earnings.
Olympus plans to unveil three new products on Wednesday, five months after the $1.7 billion fraud began to surface, including two video endoscopes for the digestive system. One of the endoscopes is aimed at emerging markets, the company said.
Better known as a camera-maker, the firm long ago used its expertise in optical technology to become a leader in diagnostic endoscopes which are used to peer inside bodies and help diagnose intestinal and stomach cancers and other illnesses.
Olympus controls about 70 percent of the global market for diagnostic endoscopes. Its major rival is fellow Japanese firm Fujifilm Holdings Corp with 10 percent.
"I think this is major," said analyst Nanako Imazu of CLSA Asia Pacific Markets, noting it was unusual for the company to call a two-hour product briefing for media and analysts.
"Every six to maybe seven years they launch new products for flexible endoscopes. At the management level they are still dysfunctional, but at the product level they may want to show that they are pretty strong," she added.
The Olympus board has yet to be fully overhauled despite being discredited by an outside investigation, though all the directors are set to be replaced at an extraordinary meeting next month when shareholders vote on a new line-up.
However, apart from a few top resignations during the course of the scandal, Olympus is being run by many of the same people who sacked the only executive who had internally challenged the firm's bookkeeping, CEO-turned-whistleblower Michael Woodford.
Five of the eight existing internal directors are being sued by Olympus for dereliction of duty.
Woodford meanwhile has failed in his campaign to be reinstated, thwarted by Japanese shareholders, and is suing the company for unfair dismissal. The Englishman is also courting public opinion, with plans to publish a book, ‘Terminated', in Japan before the April 20 meeting votes in a new board.
Olympus also plans to unveil an energy-based surgical device on Wednesday. The firm declined to give details ahead of the announcement but these kind of devices can include instruments that both cut and cauterize tissue to stem bleeding.
Most recently, Olympus released an ear, nose and throat endoscope last September, a month before the scandal broke. It had launched an ultrasonic gastrointestinal videoscope in December 2010 and a colon videoscope in August 2010.
The firm's endoscope business has proven to be remarkably resilient because it is a world away from the fickle consumer electronics business, where loyalty counts for little, product cycles are short and hot new fads rule the marketplace.
Endoscopy suites, by contrast, are major investments for customers such as hospitals and specialist clinics whose major concern during the scandal, according to anecdotal evidence, has been continued supply and after-sales service.
CLSA's Imazu said even hospitals turned off by the scandal would have little choice but to continue with Olympus for now.
"Flexible endoscopes is a five-year product cycle so ... they have to use it because they have the infrastructure of their devices installed in their hospitals," she said.
"They have no choice to change supplier right now, that's the reason why their business is pretty strong for flexible endoscopes."
(Reporting by Tim Kelly and Yoko Kubota in TOKYO; Writing by Mark Bendeich; Editing by Dean Yates)
Health
Tech
Japan
Related Quotes and News
Company
Price
Related News
Tweet this
Link this
Share this
Digg this
Email
Reprints
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (0)
Be the first to comment on reuters.com.
Add yours using the box above.
Edition:
U.S.
Africa
Arabic
Argentina
Brazil
Canada
China
France
Germany
India
Italy
Japan
Latin America
Mexico
Russia
Spain
United Kingdom
Back to top
Reuters.com
Business
Markets
World
Politics
Technology
Opinion
Money
Pictures
Videos
Site Index
Legal
Bankruptcy Law
California Legal
New York Legal
Securities Law
Support & Contact
Support
Corrections
Advertise With Us
Connect with Reuters
Twitter
Facebook
LinkedIn
RSS
Podcast
Newsletters
Mobile
About
Privacy Policy
Terms of Use
AdChoices
Copyright
Our Flagship financial information platform incorporating Reuters Insider
An ultra-low latency infrastructure for electronic trading and data distribution
A connected approach to governance, risk and compliance
Our next generation legal research platform
Our global tax workstation
Thomsonreuters.com
About Thomson Reuters
Investor Relations
Careers
Contact Us
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.